STAT+: Lilly’s Jaypirca approved as first-line CLL therapy
STAT News · LC · trust 41/100
Eli Lilly’s Jaypirca has won FDA approval for previously untreated chronic lymphocytic leukemia and small lymphocytic lymphoma.
Read the original at STAT News →
Open in TruthVane →